Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF‐κB pathway
- 11 May 2009
- journal article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 90 (3) , 355-364
Abstract
Summary: Ischaemia/reperfusion (I/R) is a major cause of heart failure. Recently cardiac stem cells (CSCs) were proposed as the most appropriate cell type for heart disease therapy. However, it is still unclear whether I/R can stimulate the CSCs homing to the injured myocardium. Male Sprague–Dawley rats were subjected to a 30‐min ischaemia followed by reperfusion of different intervals. RT‐PCR, western blotting and immunohistochemistry were performed to detect stem cell factor (SCF) expression at mRNA and protein levels respectively. Activation of nuclear factor‐κB (NF‐κB) was determined by electrophoretic mobility shift assay. To assess the homing of CSCs in vivo, BrdU‐labelled CSCs were injected into AV‐groove before induction of ischaemia and examined by immunofluorescent staining in the injured myocardium after I/R. From day 3 to day 6 after reperfusion, the accumulation of CSCs was significantly elevated in the injured area, which was matched with the increased SCF expression during I/R. Pretreatment of rats with NF‐κB inhibitor, N‐acetyl‐l‐cysteine (NAC) not only suppressed NF‐κB activation induced by I/R but also attenuated SCF expression. Further analysis revealed that I/R induced phosphorylation of IκBα after 15 min of reperfusion, and the raised phosphor‐IκBα returned to the basal level at 2 h of reperfusion. In simulated I/R(SI/R) in vitro, it enhanced NF‐κB activation and SCF expression in cultured neonatal rat cardiomyocytes, which was markedly inhibited by NF‐κB decoy oligodeoxynucleotide or NAC. Taken together, our results demonstrated that I/R induced CSCs homing to the injured myocardium by stimulating myocardial SCF expression via activation of NF‐κB.Keywords
This publication has 43 references indexed in Scilit:
- IKKβ inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cellsCardiovascular Research, 2007
- Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion InjuryCirculation, 2007
- Stem Cell Factor Attenuates Vascular Smooth Muscle Apoptosis and Increases Intimal Hyperplasia After Vascular InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Protecting the Myocardial Cell During Coronary RevascularizationCirculation, 2006
- Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokinesJournal of Clinical Investigation, 2006
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin‐1β through concerted regulation of a GRE‐like and an NF‐κB response elementThe FASEB Journal, 2003
- Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002